David Dantzker

David Dantzker

Director/Board Member at SURMODICS, INC.

Net worth: 1 M $ as of 2024-03-30

80 year
Health Technology
Commercial Services
Consumer Services

Profile

David R.
Dantzker
founded Oligomerix, Inc. in 2006, where he is working as Director from 2011.
Dr. Dantzker also founded The Feinstein Institutes for Medical Research.
Dr. Dantzker also currently works at Origin Life Sciences, Inc., as Deputy Chairman & Chief Medical Officer from 2012, Surmodics, Inc., as Independent Director from 2011, ShiftWise, Inc., as Director, Shire Regenerative Medicine, Inc., as Director, Wheatley Partners LP, as Partner, Wheatley Medtech Partners LP, as Partner from 2001, and Wheatley Partners, as Partner from 2001.
Dr. Dantzker also formerly worked at Redox Pharmaceutical Corp., as Chief Executive Officer from 2000 to 2001, Long Island Jewish Medical Center, as President & Chief Executive Officer in 1997, American Board of Internal Medicine, as Chairman, Versamed Medical Systems LLC, as Chairman, CNS, Inc. (Delaware), as Director, Datascope Corp., as Director from 2008 to 2009, Agilix Corp., as Director, Valera Pharmaceuticals, Inc., as Director from 2003 to 2007, Comprehensive NeuroScience, Inc., as Director, Physicians for Human Rights, as Treasurer & Director, Woodbrook Group Holdings, Inc., as Director, Respiri Ltd., as Independent Non-Executive Director from 2012 to 2014, NovaRay Medical, Inc., as Director, VisionSense Ltd., as Director, Care Management Technologies, Inc., as Director, Comprehensive Clinical Development, Inc., as Director, the University of Michigan, as Professor-Medicine, Northwell Health, Inc., as President in 2000, Albert Einstein College of Medicine, Inc., as Professor-Medicine, and the University of Texas at Austin, as Professor-Medicine.
Dr. Dantzker received his undergraduate degree from New York University and doctorate degree from Jacobs School of Medicine & Biomedical Sciences.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-02-07 39,124 ( 0.27% ) 1 M $ 2024-03-30

David Dantzker active positions

CompaniesPositionStart
SURMODICS, INC. Director/Board Member 2011-01-04
Director/Board Member -
Corporate Officer/Principal 2000-12-31
Wheatley Partners LP Corporate Officer/Principal -
Chief Tech/Sci/R&D Officer 2011-12-31
Founder 2005-12-31
Private Equity Investor 2000-12-31
Director/Board Member -
All active positions of David Dantzker

Former positions of David Dantzker

CompaniesPositionEnd
RESPIRI LIMITED Director/Board Member 2014-02-04
░░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of David Dantzker's experience

Training of David Dantzker

New York University Undergraduate Degree
Jacobs School of Medicine & Biomedical Sciences Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David Dantzker's experience

Connections

97

1st degree connections

31

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
SURMODICS, INC.

Health Technology

WOODBROOK GROUP HOLDINGS INC.

Finance

RESPIRI LIMITED

Health Technology

Private companies23

Retail Trade

Electronic Technology

Wheatley Partners LP

Finance

Health Technology

Finance

Commercial Services

Health Technology

Health Technology

Process Industries

Retail Trade

Health Technology

Commercial Services

Health Services

Health Services

Commercial Services

Finance

Commercial Services

Distribution Services

Commercial Services

Health Technology

Health Technology

Health Services

Commercial Services

See company connections
  1. Stock Market
  2. Insiders
  3. David Dantzker